Cigna Group $CI Stake Raised by Levin Capital Strategies L.P.

Levin Capital Strategies L.P. boosted its holdings in Cigna Group (NYSE:CI) by 193.2% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,070 shares of the health services provider’s stock after acquiring an additional 4,000 shares during the quarter. Levin Capital Strategies L.P.’s holdings in Cigna Group were worth $1,750,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. Synovus Financial Corp raised its stake in shares of Cigna Group by 3.7% during the third quarter. Synovus Financial Corp now owns 6,569 shares of the health services provider’s stock valued at $1,895,000 after purchasing an additional 233 shares in the last quarter. Signet Financial Management LLC increased its stake in Cigna Group by 0.6% during the 3rd quarter. Signet Financial Management LLC now owns 7,459 shares of the health services provider’s stock valued at $2,150,000 after buying an additional 41 shares during the period. Alberta Investment Management Corp bought a new stake in shares of Cigna Group during the 3rd quarter worth about $3,171,000. Pzena Investment Management LLC raised its position in shares of Cigna Group by 1.2% during the 3rd quarter. Pzena Investment Management LLC now owns 529,841 shares of the health services provider’s stock worth $152,727,000 after buying an additional 6,241 shares in the last quarter. Finally, CenterBook Partners LP lifted its stake in shares of Cigna Group by 148.5% in the 3rd quarter. CenterBook Partners LP now owns 4,531 shares of the health services provider’s stock worth $1,306,000 after acquiring an additional 2,708 shares during the period. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Trading Down 0.2%

Shares of NYSE CI opened at $290.24 on Thursday. Cigna Group has a 12 month low of $239.51 and a 12 month high of $350.00. The company has a market cap of $77.53 billion, a price-to-earnings ratio of 13.09, a P/E/G ratio of 1.01 and a beta of 0.27. The company has a quick ratio of 0.76, a current ratio of 0.74 and a debt-to-equity ratio of 0.74. The business has a fifty day simple moving average of $278.52 and a 200-day simple moving average of $283.99.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, topping analysts’ consensus estimates of $7.88 by $0.20. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The firm had revenue of $72.50 billion for the quarter, compared to analysts’ expectations of $69.53 billion. During the same quarter last year, the business posted $6.64 EPS. Cigna Group’s revenue was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Sell-side analysts predict that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th will be paid a $1.56 dividend. The ex-dividend date is Thursday, March 5th. This represents a $6.24 annualized dividend and a yield of 2.1%. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s dividend payout ratio (DPR) is currently 27.23%.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on CI shares. Barclays dropped their target price on Cigna Group from $305.00 to $303.00 and set an “overweight” rating on the stock in a report on Friday, February 6th. Raymond James Financial reiterated a “strong-buy” rating on shares of Cigna Group in a research report on Monday, November 3rd. JPMorgan Chase & Co. cut their price objective on Cigna Group from $428.00 to $375.00 and set an “overweight” rating for the company in a report on Tuesday, November 4th. Morgan Stanley reaffirmed an “overweight” rating and set a $355.00 target price on shares of Cigna Group in a research note on Friday, October 31st. Finally, Leerink Partners boosted their price target on shares of Cigna Group from $270.00 to $297.00 and gave the stock a “market perform” rating in a research report on Friday, February 6th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Cigna Group currently has an average rating of “Moderate Buy” and a consensus price target of $330.63.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.